Total Payments
$10,868
2024 Payments
$2,525
Companies
65
Transactions
750
Medicare Patients
9,600
Medicare Billing
$664,496
Payment Breakdown by Category
Food & Beverage$9,890 (91.0%)
Travel$877.52 (8.1%)
Education$99.99 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,890 | 747 | 91.0% |
| Travel and Lodging | $877.52 | 2 | 8.1% |
| Education | $99.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,245 | 90 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,163 | 8 | $0 (2020) |
| Novo Nordisk Inc | $820.01 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $702.29 | 35 | $0 (2024) |
| Lilly USA, LLC | $566.83 | 72 | $0 (2024) |
| Astellas Pharma US Inc | $510.15 | 22 | $0 (2024) |
| Allergan, Inc. | $504.29 | 33 | $0 (2020) |
| Amgen Inc. | $483.07 | 32 | $0 (2024) |
| PFIZER INC. | $473.63 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $406.35 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,525 | 197 | ABBVIE INC. ($479.14) |
| 2023 | $1,664 | 142 | ABBVIE INC. ($396.86) |
| 2022 | $1,141 | 86 | ABBVIE INC. ($208.03) |
| 2021 | $783.11 | 53 | AbbVie Inc. ($160.52) |
| 2020 | $1,877 | 57 | Medtronic MiniMed, Inc. ($1,163) |
| 2019 | $1,139 | 79 | Mylan Specialty L.P. ($174.14) |
| 2018 | $712.55 | 58 | Allergan Inc. ($79.68) |
| 2017 | $1,027 | 78 | Allergan Inc. ($219.93) |
All Payment Transactions
750 individual payment records from CMS Open Payments — Page 3 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neurology | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: PAIN | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Biological | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: PAIN | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardio-renal | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,218 | 3,023 | $349,838 | $155,676 |
| 2022 | 37 | 2,569 | 3,450 | $377,218 | $167,134 |
| 2021 | 38 | 2,124 | 3,223 | $349,140 | $155,935 |
| 2020 | 40 | 2,689 | 4,395 | $444,491 | $185,751 |
Total Patients
9,600
Total Services
14,091
Medicare Billing
$664,496
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 616 | $130,439 | $50,173 | 38.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 135 | 162 | $48,767 | $21,943 | 45.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 167 | 167 | $31,897 | $20,271 | 63.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 97 | $19,219 | $8,746 | 45.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 72 | 80 | $17,418 | $7,876 | 45.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 110 | $14,513 | $6,612 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 113 | $16,928 | $6,609 | 39.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $5,757 | $4,100 | 71.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 22 | $10,054 | $4,035 | 40.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 30 | 43 | $7,581 | $3,405 | 44.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 29 | $8,613 | $3,372 | 39.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 125 | 136 | $4,781 | $2,239 | 46.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 152 | 161 | $4,508 | $2,112 | 46.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $5,585 | $1,988 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 238 | $3,495 | $1,985 | 56.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 161 | 172 | $3,806 | $1,780 | 46.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 83 | 167 | $2,979 | $1,580 | 53.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 162 | 176 | $2,309 | $1,339 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 58 | 58 | $1,102 | $1,080 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 23 | 24 | $2,568 | $945.36 | 36.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 34 | 36 | $1,404 | $648.72 | 46.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 29 | 29 | $1,131 | $548.68 | 48.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 69 | 72 | $936.00 | $407.52 | 43.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 72 | 75 | $675.00 | $381.00 | 56.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 20 | $640.00 | $295.60 | 46.2% |
About Dr. Troy Lunceford, MD
Dr. Troy Lunceford, MD is a Internal Medicine healthcare provider based in Salem, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194842286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Troy Lunceford, MD has received a total of $10,868 in payments from pharmaceutical and medical device companies, with $2,525 received in 2024. These payments were reported across 750 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($9,890).
As a Medicare-enrolled provider, Lunceford has provided services to 9,600 Medicare beneficiaries, totaling 14,091 services with total Medicare billing of $664,496. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Salem, UT
- Active Since 03/23/2007
- Last Updated 11/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194842286
Products in Payments
- Minimed 670G System (Device) $1,163
- VRAYLAR (Drug) $736.43
- UBRELVY (Drug) $528.24
- Ozempic (Drug) $476.50
- FARXIGA (Drug) $378.73
- MOUNJARO (Drug) $301.06
- JARDIANCE (Drug) $295.29
- XARELTO (Drug) $286.40
- Veozah (Drug) $274.14
- NURTEC ODT (Drug) $234.39
- LATUDA (Drug) $229.70
- QULIPTA (Drug) $225.38
- Yupelri (Drug) $209.38
- TRADJENTA (Drug) $180.19
- ZENPEP (Drug) $171.40
- Rybelsus (Drug) $162.87
- Kerendia (Drug) $153.40
- SOLIQUA 100/33 (Biological) $145.08
- AIRSUPRA (Drug) $144.39
- LEQVIO (Drug) $144.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Internal Medicine $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Internal Medicine $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
Internal Medicine $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Internal Medicine $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Internal Medicine $11,191
Dr. Marshall Bahr, Md, Mba, MD, MBA
Internal Medicine — Payments: $10,601
Internal Medicine $10,601